Re: Google Eres Un Robot
Vanina Mazzillo
Capitan Memo's song "Robot, Eres Formidable" is a tribute to the classic trope of the heroic robot, a figure that has been a staple in science fiction and popular culture. The lyrics paint a vivid picture of a robot that is not only powerful but also driven by a sense of justice and love. This robot traverses the universe at the speed of light, always ready to confront evil and transform its body into metal to face any threat. The imagery of a robot with secret weapons and the ability to change form underscores its invincibility and readiness to protect the innocent.
The song emphasizes the robot's role as a justiciero, or avenger, highlighting its commitment to fighting for what is right. The robot's ability to leap into the blue sky and transform into a giant robot with the movement of its fists symbolizes its strength and determination. This transformation can be seen as a metaphor for the inner strength and resilience that individuals can summon when faced with adversity. The repeated mention of the robot's secret weapons and its invincibility serves to inspire confidence and a sense of security in the listener.
Capitan Memo, known for his contributions to the soundtracks of various animated series, often infuses his music with themes of heroism and adventure. "Robot, Eres Formidable" is no exception, capturing the essence of a heroic journey through its dynamic and uplifting lyrics. The song resonates with listeners who appreciate stories of bravery and the triumph of good over evil, making it a timeless piece that continues to inspire and entertain.
Vivo Surgical is a patient-focused, clinician-driven medtech developer and manufacturer. The start-up works closely with clinicians to ensure its products are designed and developed to address specific medical needs.
Headquartered in Singapore with a commercial presence in multiple international territories, the company is pioneering a novel and differentiated endoscopic robot for complex endoluminal surgeries along the gastrointestinal tract. Through co-innovation partnerships spanning areas from in-cavity surgical lighting to flexible endoscopy, Vivo Surgical fosters a close collaboration with leading clinical key opinion leaders, health systems, and research institutes to accelerate the implementation and adoption of its proprietary technologies.
ISO 13485 certified with international safety accreditations such as the Food and Drug Administration and CE mark, Vivo Surgical places a firm emphasis on having strong intellectual property (IP) protection to further enhance the credibility and robustness of the business. This has paved the way for strategic business and technology collaborations with larger international players, accelerating the downstream commercialisation of its innovations for the global healthcare market.
Vivo Surgical gained a clearer picture of its existing IA portfolio and associated risks. Following the review, the company expanded its IA portfolio to protect its technologies and business more comprehensively. In addition to patents, Vivo Surgical uses trade secrets, registered designs, and trade marks in its holistic IA protection strategy. The company also leverages regulatory approvals and strategic partnerships to safeguard its competitive advantages in its key markets.
SINGAPORE, May 2, 2024 /PRNewswire/ -- Vivo Surgical Private Limited, a privately-held surgical technology company pioneering a flexible endoscopic robot for advanced endoscopic resections, is excited to unveil its inaugural International Clinical Advisory Board. Comprising distinguished Key Opinion Leaders (KOLs) in the field of therapeutic gastrointestinal (GI) endoscopy, the board is poised to provide strategic guidance and expertise to Vivo Surgical as it continues to drive advancements in minimally invasive surgical robotic technology.
Dr Saito is internationally recognized for his expertise in the fields of colonoscopy, advanced endoscopic imaging and endoscopic submucosal dissection (ESD). At present, he is Director of the Endoscopy Center at the National Cancer Center Hospital (Tokyo, Japan), serving also as Chief of its Endoscopy Division. Dr Saito holds fellowships in several prominent gastroenterological societies, such as the American Society for Gastrointestinal Endoscopy (FASGE) and Japanese Gastrointestinal Endoscopy Society (FJGES), and was honoured with the UAB Basil Hirschowitz Master Endoscopist Award for his global contributions to the advancement of endoscopy.
Dr Zhou holds esteemed positions at Zhongshan Hospital of Fudan University in Shanghai, serving as Professor of Surgery and Director of its Endoscopy Centre. He plays pivotal roles in shaping the landscape of digestive endoscopy, serving as Vice Chairman of the Digestive Endoscopy Society within the Chinese Medical Association and is the incoming Chair of the Shanghai Medical Association of Digestive Endoscopy. Dr Zhou is internationally recognized for his expertise in therapeutic endoscopy, endoscopic submucosal dissection (ESD) and per-oral endoscopic myotomy (POEM), and is a Fellow of the American Society for Gastrointestinal Endoscopy (FASGE).
Dr Khor is a prominent figure in gastroenterology, holding such positions as Senior Consultant at Singapore General Hospital (SGH) and Clinical Associate Professor at Duke-NUS Medical School (Singapore). With leadership roles at SGH, he is recognized for his expertise in therapeutic gastrointestinal endoscopy, colonoscopy and endoscopic submucosal dissection (ESD). Besides being a Fellow of the American Society of Gastrointestinal Endoscopy (FASGE), Dr Khor is also actively involved in other professional societies, serving as President of the GI-Taskforce Asia Pacific and previously as President of the Gastroenterological Society of Singapore, contributing significantly to the field's advancement both locally and internationally.
d3342ee215